Clinical Trial Update: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE) [Phase 2]

View source ↗

Summary

A Phase 2 Core OLE study of rodatristat ethyl in patients with pulmonary arterial hypertension has completed, and results were posted on 2025-06-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Rodatristat Ethyl (rodatristat ethyl)

Snippet

Sponsor: Altavant Sciences GmbH | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-06-04